Adeno-associated virus-based gene therapy for CNS diseases

M Hocquemiller, L Giersch, M Audrain… - Human gene …, 2016 - liebertpub.com
Gene therapy is at the cusp of a revolution for treating a large spectrum of CNS disorders by
providing a durable therapeutic protein via a single administration. Adeno-associated virus …

[HTML][HTML] ROCK inhibition in models of neurodegeneration and its potential for clinical translation

JC Koch, L Tatenhorst, AE Roser, KA Saal… - Pharmacology & …, 2018 - Elsevier
Neurodegenerative disorders like Parkinson's disease, Alzheimer's disease, or amyotrophic
lateral sclerosis are affecting a rapidly increasing population worldwide. While common …

Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease

L Tatenhorst, K Eckermann, V Dambeck… - Acta neuropathologica …, 2016 - Springer
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, yet
disease-modifying treatments do not currently exist. Rho-associated protein kinase (ROCK) …

Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons

JC Koch, F Bitow, J Haack, Z d'Hedouville… - Cell death & …, 2015 - nature.com
Many neuropathological and experimental studies suggest that the degeneration of
dopaminergic terminals and axons precedes the demise of dopaminergic neurons in the …

Intra-CSF AAV9 and AAVrh10 administration in nonhuman primates: promising routes and vectors for which neurological diseases?

K Bey, J Deniaud, L Dubreil, B Joussemet… - … Therapy Methods & …, 2020 - cell.com
The identification of the most efficient method for whole central nervous system targeting that
is translatable to humans and the safest route of adeno-associated virus (AAV) …

The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders

J Eira, CS Silva, MM Sousa, MA Liz - Progress in Neurobiology, 2016 - Elsevier
Cytoskeleton defects, including alterations in microtubule stability, in axonal transport as
well as in actin dynamics, have been characterized in several unrelated neurodegenerative …

ROCK2 inhibition: A futuristic approach for the management of Alzheimer's disease

S Mani, D Jindal, H Chopra, SK Jha, SK Singh… - Neuroscience & …, 2022 - Elsevier
Neurons depend on mitochondrial functions for membrane excitability, neurotransmission,
and plasticity. Mitochondrial dynamics are important for neural cell maintenance. To …

Role of RhoA-ROCK signaling in Parkinson's disease

M Iyer, MD Subramaniam, D Venkatesan… - European journal of …, 2021 - Elsevier
Parkinson's disease (PD) is a complex and widespread neurodegenerative disease
characterized by depletion of midbrain dopaminergic (DA) neurons. Key issues are the …

CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models

IK Timotius, RF Roelofs… - Frontiers in Behavioral …, 2023 - frontiersin.org
Automated gait assessment tests are used in studies of disorders characterized by gait
impairment. CatWalk XT is one of the first commercially available automated systems for …

Modulation of microglial activity by Rho-kinase (ROCK) inhibition as therapeutic strategy in Parkinson's disease and amyotrophic lateral sclerosis

AE Roser, L Tönges, P Lingor - Frontiers in aging neuroscience, 2017 - frontiersin.org
Neurodegenerative diseases are characterized by the progressive degeneration of neurons
in the central and peripheral nervous system (CNS, PNS), resulting in a reduced innervation …